Company intelligence / Profile preview

Bofors Nobelkrut

Karlskoga, Sweden

Ownership: Private
Development stage: Other

Overview

Bofors Nobelkrut was the chemical and explosives division of the Swedish industrial giant Bofors, acquired by Alfred Nobel in 1894. Over the 20th century, the company leveraged its expertise in nitration and complex organic chemistry to transition from explosives into fine chemicals and pharmaceutical intermediates. Today, the legacy of Bofors Nobelkrut lives on through Cambrex Karlskoga, a leading contract development and manufacturing organization (CDMO) specializing in small molecule drug substances. The company is historically significant for its role in the development of the Swedish chemical industry and its eventual pivot to supporting the global life sciences sector.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Bofors Nobelkrut.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bofors Nobelkrut.

Explore the full profile